General Catalyst Group Management, LLC reported 14 positions worth $188.52M for the quarter ended Jun 30, 2026, up 2.7% on the prior quarter. It opened 4 new positions, added to 3, trimmed 1 and exited 2. Its largest holding is ArriVent BioPharma, Inc. at 27.5% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| PBLS Parabilis Medicines, Inc. | +1.60M | – | $43.82M | 23.24% |
| ODTX Odyssey Therapeutics, Inc. | +810.3K | – | $15.16M | 8.04% |
| DASH DoorDash, Inc. | +2,850 | – | $525.91K | 0.279% |
| CVNA Carvana Co. | +6,465 | – | $425.53K | 0.226% |
| META Meta Platforms, Inc. | +662 | +100.6% | $372.90K | 0.394% |
| CPNG Coupang, Inc. | +18.0K | +49.1% | $312.66K | 0.504% |
| AMZN Amazon Com Inc | +1,300 | +50.3% | $309.84K | 0.491% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | AVBP ArriVent BioPharma, Inc. | Healthcare | 1.49M | $51.93M | 27.55% | 0 | 0.0% | Unchanged | 3.09% |
| 2 | PBLS Parabilis Medicines, Inc. | Healthcare | 1.60M | $43.82M | 23.24% | +1.60M | – | New | 1.31% |
| 3 | CART Maplebear Inc. | Technology | 710.7K | $33.65M | 17.85% | 0 | 0.0% | Unchanged | 0.3% |
| 4 | MAZE Maze Therapeutics, Inc. | Healthcare | 1.04M | $30.91M | 16.4% | 0 | 0.0% | Unchanged | 1.76% |
| 5 | ODTX Odyssey Therapeutics, Inc. | Healthcare | 810.3K | $15.16M | 8.04% | +810.3K | – | New | 1.69% |
| 6 | EIKN Eikon Therapeutics, Inc. | Healthcare | 305.2K | $3.98M | 2.11% | 0 | 0.0% | Unchanged | 0.56% |
| 7 | GUTS Fractyl Health, Inc. | Healthcare | 407.0K | $3.88M | 2.06% | -1 | 0.0% | Reduced | 3.08% |
| 8 | LIFE Ethos Technologies Inc. | Healthcare | 74.2K | $1.35M | 0.714% | 0 | 0.0% | Unchanged | 0.12% |
| 9 | CPNG Coupang, Inc. | Consumer Discretionary | 54.7K | $949.74K | 0.504% | +18.0K | +49.1% | Added | 0% |
| 10 | AMZN Amazon Com Inc | Consumer Discretionary | 3,882 | $925.24K | 0.491% | +1,300 | +50.3% | Added | 0% |
| 11 | META Meta Platforms, Inc. | Technology | 1,320 | $743.54K | 0.394% | +662 | +100.6% | Added | 0% |
| 12 | DASH DoorDash, Inc. | Technology | 2,850 | $525.91K | 0.279% | +2,850 | – | New | 0% |
| 13 | CVNA Carvana Co. | Consumer Discretionary | 6,465 | $425.53K | 0.226% | +6,465 | – | New | 0% |
| 14 | FIG Figma, Inc. | Technology | 14.8K | $268.55K | 0.142% | 0 | 0.0% | Unchanged | 0% |
Tip. Select a row to see that position’s full history at General Catalyst Group Management.
As of its Q2 2026 13F filing, General Catalyst Group Management, LLC’s five largest positions were ArriVent BioPharma, Inc. (AVBP) at 27.5%, Parabilis Medicines, Inc. (PBLS) at 23.2%, Maplebear Inc. (CART) at 17.9%, Maze Therapeutics, Inc. (MAZE) at 16.4%, Odyssey Therapeutics, Inc. (ODTX) at 8.0% of the reported portfolio.
General Catalyst Group Management, LLC reported a 13F portfolio worth $188.52M across 14 positions for Q2 2026. That is up 2.7% from the previous quarter.
Its largest purchases by value were Parabilis Medicines, Inc. ($43.82M), Odyssey Therapeutics, Inc. ($15.16M), DoorDash, Inc. ($525.91K). It opened 4 new positions.
Its largest sales by value were Samsara Inc. ($63.38M), Gitlab Inc. ($19.94M), Fractyl Health, Inc. ($5.56). It exited 2 positions entirely.
From the Form 13F-HR reports General Catalyst Group Management, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.